About the Author
Dr. Patrick Rynn Hogan, DHA is a healthcare executive, strategist, and national advocate focused on the intersection of public health, economics, and systems-level reform. With a Doctorate in Health Administration and decades of experience spanning healthcare operations, analytics, governance, and policy strategy, Dr. Hogan brings a rare multidisciplinary lens to complex global health challenges.
His work centers on identifying structural vulnerabilities within healthcare systems — particularly where epidemiology, economics, and operational design intersect. Throughout his career, he has led large-scale transformation initiatives, advised executive leadership teams, and worked across clinical, regulatory, and technology domains to improve performance, accountability, and outcomes.
Dr. Hogan is known for translating complex scientific and policy issues into actionable frameworks for decision-makers. His expertise spans antimicrobial stewardship strategy, healthcare infrastructure risk, population health economics, and data-driven modernization efforts. He approaches public health threats not solely as clinical problems, but as interconnected system failures requiring coordinated reform across government, industry, and healthcare delivery.
In The Silent Pandemic of Antimicrobial Resistance, Dr. Hogan applies this systems-oriented perspective to one of the most consequential threats of our time. Drawing from epidemiological data, economic modeling, and operational insight, he frames antimicrobial resistance as a slow-moving but accelerating crisis that demands disciplined execution, not passive awareness.
Dr. Hogan’s work is guided by a central conviction: sustainable health security requires structural accountability, measurable progress, and cross-sector collaboration. Through his writing, speaking, and advisory efforts, he seeks to elevate antimicrobial resistance from a technical concern to a strategic priority for leaders across healthcare, policy, and industry.
He lives and works in the United States, where he continues to focus on advancing resilient, data-driven approaches to modern healthcare challenges.
